Biotechnology M&A » By The Online Investor Staff, updated Thu., May. 9, 9:30 AM
Recent mergers and acquisitions in the Biotechnology M&A category.
Slide #8. AMRI — Cedarburg Pharmaceuticals, Inc.
Acquirer: |
AMRI (AMRI) |
Acquiree: |
Cedarburg Pharmaceuticals, Inc. |
Details: |
AMRI (NASDAQ: AMRI) today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc. |
Albany Molecular Research is a contract research and manufacturing organization providing customers integrated drug discovery, development, and manufacturing services. Co. has three segments: Discovery and Development Services, which include provides a range of chemical development technologies for route development; Active Pharmaceutical Ingredients, which provides chemical synthesis and manufacturing services for its customers; drug product, which provides facilities to deliver integrated pharmaceutical drug development programs and services; and Fine Chemicals, which provides lab to commercial scale synthesis of reagents and diverse compounds to the pharmaceutical, among others.
Open the AMRI Page at The Online Investor »
Open the AMRI Page at The Online Investor (in a new window) »
|
May 9, 2024 9:30 AM Eastern
Hold (2.00 out of 4)
100th percentile
|
|